Hochdosierte Methotrexatbehandlung: Indikationen, Risiken, Steuerung
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | German |
| Veröffentlicht: |
München [u.a.]
Urban & Schwarzenberg
1983
|
| Schlagworte: | |
| Beschreibung: | XI, 359 S. graph. Darst. |
| ISBN: | 3541124016 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV000255965 | ||
| 003 | DE-604 | ||
| 005 | 20151125 | ||
| 007 | t | ||
| 008 | 870612s1983 d||| |||| 00||| ger d | ||
| 020 | |a 3541124016 |9 3-541-12401-6 | ||
| 035 | |a (OCoLC)230651071 | ||
| 035 | |a (DE-599)BVBBV000255965 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a ger | |
| 049 | |a DE-12 |a DE-19 |a DE-29 |a DE-188 | ||
| 084 | |a XI 6600 |0 (DE-625)153022:12905 |2 rvk | ||
| 084 | |a MED 970f |2 stub | ||
| 100 | 1 | |a Jürgens, Herbert |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Hochdosierte Methotrexatbehandlung |b Indikationen, Risiken, Steuerung |c Herbert Jürgens |
| 264 | 1 | |a München [u.a.] |b Urban & Schwarzenberg |c 1983 | |
| 300 | |a XI, 359 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 4 | |a Methotrexate |x poisoning | |
| 650 | 0 | 7 | |a Pharmakodynamik |0 (DE-588)4174134-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Methotrexat |0 (DE-588)4038985-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Therapie |0 (DE-588)4059798-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakokinetik |0 (DE-588)4115557-9 |2 gnd |9 rswk-swf |
| 655 | 7 | |a Methodtrexat |2 gnd |9 rswk-swf | |
| 689 | 0 | 0 | |a Methotrexat |0 (DE-588)4038985-6 |D s |
| 689 | 0 | 1 | |a Therapie |0 (DE-588)4059798-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 1 | 1 | |a Methodtrexat |A f |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Methotrexat |0 (DE-588)4038985-6 |D s |
| 689 | 2 | 1 | |a Pharmakodynamik |0 (DE-588)4174134-1 |D s |
| 689 | 2 | |5 DE-604 | |
| 689 | 3 | 0 | |a Methotrexat |0 (DE-588)4038985-6 |D s |
| 689 | 3 | 1 | |a Pharmakokinetik |0 (DE-588)4115557-9 |D s |
| 689 | 3 | |5 DE-604 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-000154598 | ||
Datensatz im Suchindex
| _version_ | 1804114721960361984 |
|---|---|
| any_adam_object | |
| author | Jürgens, Herbert |
| author_facet | Jürgens, Herbert |
| author_role | aut |
| author_sort | Jürgens, Herbert |
| author_variant | h j hj |
| building | Verbundindex |
| bvnumber | BV000255965 |
| classification_rvk | XI 6600 |
| classification_tum | MED 970f |
| ctrlnum | (OCoLC)230651071 (DE-599)BVBBV000255965 |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01744nam a2200505 c 4500</leader><controlfield tag="001">BV000255965</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20151125 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">870612s1983 d||| |||| 00||| ger d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3541124016</subfield><subfield code="9">3-541-12401-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)230651071</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV000255965</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">ger</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 6600</subfield><subfield code="0">(DE-625)153022:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MED 970f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Jürgens, Herbert</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Hochdosierte Methotrexatbehandlung</subfield><subfield code="b">Indikationen, Risiken, Steuerung</subfield><subfield code="c">Herbert Jürgens</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">München [u.a.]</subfield><subfield code="b">Urban & Schwarzenberg</subfield><subfield code="c">1983</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XI, 359 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Methotrexate</subfield><subfield code="x">poisoning</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakodynamik</subfield><subfield code="0">(DE-588)4174134-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Methotrexat</subfield><subfield code="0">(DE-588)4038985-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakokinetik</subfield><subfield code="0">(DE-588)4115557-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Methodtrexat</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Methotrexat</subfield><subfield code="0">(DE-588)4038985-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Methodtrexat</subfield><subfield code="A">f</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Methotrexat</subfield><subfield code="0">(DE-588)4038985-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Pharmakodynamik</subfield><subfield code="0">(DE-588)4174134-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Methotrexat</subfield><subfield code="0">(DE-588)4038985-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="1"><subfield code="a">Pharmakokinetik</subfield><subfield code="0">(DE-588)4115557-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-000154598</subfield></datafield></record></collection> |
| genre | Methodtrexat gnd |
| genre_facet | Methodtrexat |
| id | DE-604.BV000255965 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T15:11:14Z |
| institution | BVB |
| isbn | 3541124016 |
| language | German |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-000154598 |
| oclc_num | 230651071 |
| open_access_boolean | |
| owner | DE-12 DE-19 DE-BY-UBM DE-29 DE-188 |
| owner_facet | DE-12 DE-19 DE-BY-UBM DE-29 DE-188 |
| physical | XI, 359 S. graph. Darst. |
| publishDate | 1983 |
| publishDateSearch | 1983 |
| publishDateSort | 1983 |
| publisher | Urban & Schwarzenberg |
| record_format | marc |
| spelling | Jürgens, Herbert Verfasser aut Hochdosierte Methotrexatbehandlung Indikationen, Risiken, Steuerung Herbert Jürgens München [u.a.] Urban & Schwarzenberg 1983 XI, 359 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Methotrexate poisoning Pharmakodynamik (DE-588)4174134-1 gnd rswk-swf Methotrexat (DE-588)4038985-6 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Therapie (DE-588)4059798-2 gnd rswk-swf Pharmakokinetik (DE-588)4115557-9 gnd rswk-swf Methodtrexat gnd rswk-swf Methotrexat (DE-588)4038985-6 s Therapie (DE-588)4059798-2 s DE-604 Krebs Medizin (DE-588)4073781-0 s Methodtrexat f Pharmakodynamik (DE-588)4174134-1 s Pharmakokinetik (DE-588)4115557-9 s |
| spellingShingle | Jürgens, Herbert Hochdosierte Methotrexatbehandlung Indikationen, Risiken, Steuerung Methotrexate poisoning Pharmakodynamik (DE-588)4174134-1 gnd Methotrexat (DE-588)4038985-6 gnd Krebs Medizin (DE-588)4073781-0 gnd Therapie (DE-588)4059798-2 gnd Pharmakokinetik (DE-588)4115557-9 gnd |
| subject_GND | (DE-588)4174134-1 (DE-588)4038985-6 (DE-588)4073781-0 (DE-588)4059798-2 (DE-588)4115557-9 |
| title | Hochdosierte Methotrexatbehandlung Indikationen, Risiken, Steuerung |
| title_auth | Hochdosierte Methotrexatbehandlung Indikationen, Risiken, Steuerung |
| title_exact_search | Hochdosierte Methotrexatbehandlung Indikationen, Risiken, Steuerung |
| title_full | Hochdosierte Methotrexatbehandlung Indikationen, Risiken, Steuerung Herbert Jürgens |
| title_fullStr | Hochdosierte Methotrexatbehandlung Indikationen, Risiken, Steuerung Herbert Jürgens |
| title_full_unstemmed | Hochdosierte Methotrexatbehandlung Indikationen, Risiken, Steuerung Herbert Jürgens |
| title_short | Hochdosierte Methotrexatbehandlung |
| title_sort | hochdosierte methotrexatbehandlung indikationen risiken steuerung |
| title_sub | Indikationen, Risiken, Steuerung |
| topic | Methotrexate poisoning Pharmakodynamik (DE-588)4174134-1 gnd Methotrexat (DE-588)4038985-6 gnd Krebs Medizin (DE-588)4073781-0 gnd Therapie (DE-588)4059798-2 gnd Pharmakokinetik (DE-588)4115557-9 gnd |
| topic_facet | Methotrexate poisoning Pharmakodynamik Methotrexat Krebs Medizin Therapie Pharmakokinetik Methodtrexat |
| work_keys_str_mv | AT jurgensherbert hochdosiertemethotrexatbehandlungindikationenrisikensteuerung |